Global Retinoblastoma Treatment Outcomes: Association with National Income Level.
Brachytherapy
Child, Preschool
Databases, Factual
Eye Enucleation
Female
Global Health
Humans
Income
/ statistics & numerical data
Infant
Male
Medical Oncology
Registries
Retinal Neoplasms
/ economics
Retinoblastoma
/ economics
Retrospective Studies
Salvage Therapy
Treatment Failure
Treatment Outcome
Country
Global
Income
Outcomes
Retinoblastoma
Journal
Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
28
07
2020
revised:
17
09
2020
accepted:
21
09
2020
pubmed:
3
10
2020
medline:
9
10
2021
entrez:
2
10
2020
Statut:
ppublish
Résumé
To compare metastasis-related mortality, local treatment failure, and globe salvage after retinoblastoma in countries with different national income levels. International, multicenter, registry-based retrospective case series. Two thousand one hundred ninety patients, 18 ophthalmic oncology centers, and 13 countries on 6 continents. Multicenter registry-based data were pooled from retinoblastoma patients enrolled between January 2001 and December 2013. Adequate data to allow American Joint Committee on Cancer staging, eighth edition, and analysis for the main outcome measures were available for 2085 patients. Each country was classified by national income level, as defined by the 2017 United Nations World Population Prospects, and included high-income countries (HICs), upper middle-income countries (UMICs), and lower middle-income countries (LMICs). Patient survival was estimated with the Kaplan-Meier method. Logistic and Cox proportional hazards regression models were used to determine associations between national income and treatment outcomes. Metastasis-related mortality and local treatment failure (defined as use of secondary enucleation or external beam radiation therapy). Most (60%) study patients resided in UMICs and LMICs. The global median age at diagnosis was 17.0 months and higher in UMICs (20.0 months) and LMICs (20.0 months) than HICs (14.0 months; P < 0.001). Patients in UMICs and LMICs reported higher rates of disease-specific metastasis-related mortality and local treatment failure. As compared with HICs, metastasis-related mortality was 10.3-fold higher for UMICs and 9.3-fold higher for LMICs, and the risk for local treatment failure was 2.2-fold and 1.6-fold higher, respectively (all P < 0.001). This international, multicenter, registry-based analysis of retinoblastoma management revealed that lower national income levels were associated with significantly higher rates of metastasis-related mortality, local treatment failure, and lower globe salvage.
Identifiants
pubmed: 33007338
pii: S0161-6420(20)30957-X
doi: 10.1016/j.ophtha.2020.09.032
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
740-753Informations de copyright
Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.